Sinopia Biosciences' Grant - IV Round

Sinopia Biosciences raised a round of funding on September 13, 2016. Investors include National Institute of General Medical Sciences.

Sinopia is a computational biology company focusing on identifying and repurposing drugs to prevent or lower the serious side effects of major therapeutics. The company uses its proprietary machine le…

Articles about Sinopia Biosciences' Grant - IV Round: